Elamin Yasir, AlAnazi AlAnoud, Al Saeed Zahra A, Alabdrabalnabi Fatimah M
AACE Clin Case Rep. 2020 Aug 6;6(6):e295-e299. doi: 10.4158/ACCR-2020-0141. eCollection 2020 Nov-Dec.
We report a case of adipsic diabetes insipidus (ADI) post-astrocytoma resection.
Clinical and laboratory data are presented.
A 16-year-old female with a history of incompletely resected hypothalamic astrocytoma was admitted with a headache. Head magnetic resonance imaging showed an interval increase in a suprasellar lesion with extension to the third ventricle. Following a second stage resection, she developed an increased urine output with diluted urine resulting in a negative fluid balance; however, she was unable to sense thirst. Blood tests showed a serum sodium of 155 mEq/dL (normal, 136 to 145 mEq/dL), serum osmolality at 321 mOs/kg (normal, 285 to 295 mOs/kg) and a urine osmolality of 128 mOsm/kg (normal, 300 to 1,600 mOsm/kg). Serum creatinine and potassium were normal. Pituitary hormone profiles were found to be normal: growth hormone 0.171 ng/mL (normal, 0.123 to 8.05 ng/mL), luteinizing hormone 3.44 mIU/mL (normal, 7.59 to 89.08 mIU/mL), follicle-stimulating hormone 5.60 mIU/mL (normal, 2.55 to 16.69 mIU/mL), thyroid-stimulating hormone 2.9 mIU/mL (normal, 0.35 to 4.94 mIU/mL), free thyroxine 0.92 ng/dL (normal, 0.7 to 1.48 ng/dL), adrenocorticotropic hormone 19.56 pg/mL (normal, 7.2 to 63.3 pg/mL), and prolactin 7.25 ng/mL (normal, 5.18 to 26.53 ng/mL). The patient was treated with desmopressin acetate 120 μg tablets twice daily with a fixed fluid intake of 1.5 to 2.0 L/day with close monitoring of fluid intake, output, and body weight. The response was good with a gradual reduction of serum sodium level of around 7 to 9 mEq/L/day.
ADI is a rare entity of central diabetes insipidus, where the absence of polydipsia can be challenging in diagnosing and managing the condition. Cases of ADI are likely under reported and clinicians need to be aware of this condition.
我们报告一例星形细胞瘤切除术后发生的无渴感型尿崩症(ADI)病例。
呈现临床和实验室数据。
一名16岁女性,有下丘脑星形细胞瘤不完全切除病史,因头痛入院。头部磁共振成像显示鞍上病变范围扩大并延伸至第三脑室。在二期切除术后,她出现尿量增加且尿液稀释,导致液体负平衡;然而,她无法感知口渴。血液检查显示血清钠为155 mEq/dL(正常范围136至145 mEq/dL),血清渗透压为321 mOs/kg(正常范围285至295 mOs/kg),尿渗透压为128 mOsm/kg(正常范围300至1600 mOsm/kg)。血清肌酐和钾正常。垂体激素水平正常:生长激素0.171 ng/mL(正常范围0.123至8.05 ng/mL),促黄体生成素3.44 mIU/mL(正常范围7.59至89.08 mIU/mL),促卵泡生成素5.60 mIU/mL(正常范围2.55至16.69 mIU/mL),促甲状腺激素2.9 mIU/mL(正常范围0.35至4.94 mIU/mL),游离甲状腺素0.92 ng/dL(正常范围0.7至1.48 ng/dL),促肾上腺皮质激素19.56 pg/mL(正常范围7.2至63.3 pg/mL),催乳素7.25 ng/mL(正常范围5.18至26.53 ng/mL)。该患者接受醋酸去氨加压素120 μg片剂治疗,每日两次,固定液体摄入量为1.5至2.0 L/天,并密切监测液体摄入、输出和体重。反应良好,血清钠水平每天逐渐降低约7至9 mEq/L。
ADI是中枢性尿崩症的一种罕见类型,其中无烦渴感在该病的诊断和管理中可能具有挑战性。ADI病例可能报告不足,临床医生需要了解这种情况。